News + Filings Holdings
|
GEODE CAPITAL MANAGEMENT, LLC
> RVNC
Date | Name | Ticker | Shares | Change | Value | Change | Price |
06/30/2023 | Revance Therapeutics, Inc. | RVNC | 1,695,510 | 98,996 | 42,913,374,000 | -8,510,364,000 | $25,310.01 |
03/31/2023 | Revance Therapeutics, Inc. | RVNC | 1,596,514 | 213,273 | 51,423,738,000 | 51,386,391,000 | $32,210.01 |
09/30/2022 | Revance Therapeutics, Inc. | RVNC | 1,383,241 | 146,289 | 37,347,000 | 20,253,000 | $27.00 |
06/30/2022 | Revance Therapeutics, Inc. | RVNC | 1,236,952 | -99,239 | 17,094,000 | -8,961,000 | $13.82 |
03/31/2022 | Revance Therapeutics, Inc. | RVNC | 1,336,191 | 24,111 | 26,055,000 | 4,642,000 | $19.50 |
12/31/2021 | Revance Therapeutics, Inc. | RVNC | 1,312,080 | 107,692 | 21,413,000 | -12,141,000 | $16.32 |
09/30/2021 | Revance Therapeutics, Inc. | RVNC | 1,204,388 | 577 | 33,554,000 | -2,126,000 | $27.86 |
06/30/2021 | Revance Therapeutics, Inc. | RVNC | 1,203,811 | 83,303 | 35,680,000 | 4,362,000 | $29.64 |
03/31/2021 | Revance Therapeutics, Inc. | RVNC | 1,120,508 | 128,414 | 31,318,000 | 3,203,000 | $27.95 |
12/31/2020 | Revance Therapeutics, Inc. | RVNC | 992,094 | 51,418 | 28,115,000 | 4,467,000 | $28.34 |
09/30/2020 | Revance Therapeutics, Inc. | RVNC | 940,676 | 143,224 | 23,648,000 | 4,175,000 | $25.14 |
06/30/2020 | Revance Therapeutics, Inc. | RVNC | 797,452 | 73,582 | 19,473,000 | 8,760,000 | $24.42 |
03/31/2020 | Revance Therapeutics, Inc. | RVNC | 723,870 | 136,718 | 10,713,000 | 1,184,000 | $14.80 |
12/31/2019 | Revance Therapeutics, Inc. | RVNC | 587,152 | 26,038 | 9,529,000 | 2,252,000 | $16.23 |
06/30/2019 | Revance Therapeutics, Inc. | RVNC | 561,114 | 72,767 | 7,277,000 | -419,000 | $12.97 |
03/31/2019 | Revance Therapeutics, Inc. | RVNC | 488,347 | 102,529 | 7,696,000 | -70,000 | $15.76 |
12/31/2018 | Revance Therapeutics, Inc. | RVNC | 385,818 | 48,325 | 7,766,000 | -620,000 | $20.13 |
09/30/2018 | Revance Therapeutics, Inc. | RVNC | 337,493 | 33,404 | 8,386,000 | 39,000 | $24.85 |
06/30/2018 | Revance Therapeutics, Inc. | RVNC | 304,089 | 41,697 | 8,347,000 | 266,000 | $27.45 |
03/31/2018 | Revance Therapeutics, Inc. | RVNC | 262,392 | 42,831 | 8,081,000 | 232,000 | $30.80 |
12/31/2017 | Revance Therapeutics, Inc. | RVNC | 219,561 | 16,541 | 7,849,000 | 2,256,000 | $35.75 |
09/30/2017 | Revance Therapeutics, Inc. | RVNC | 203,020 | 11,129 | 5,593,000 | 528,000 | $27.55 |
06/30/2017 | Revance Therapeutics, Inc. | RVNC | 191,891 | 13,456 | 5,065,000 | 5,061,289 | $26.40 |
03/31/2017 | Revance Therapeutics, Inc. | RVNC | 178,435 | 178,435 | 3,711 | 3,711 | $0.02 |
<< Prev Next >> |
|